Video Latest - ecancer

ESMO 2016 conference highlights

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

12 Oct 2016

Left versus right sided GI tumour response in the CRYSTAL trial

Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium

10 Oct 2016

Looking for new pathways in colorectal cancer

Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark

10 Oct 2016

Lurbinectedin in PARP resistant breast cancer

Dr Cristina Cruz - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

10 Oct 2016

Lurbinectedin in BRCA 1/2 breast cancer

Dr Judith Balmaña - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

10 Oct 2016

Olaparib and paclitaxel for 2nd line gastric cancer therapy

Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea

10 Oct 2016

Comment: Ribociclib for breast cancer

Dr Evandro De Azambuja - ‎Jules Bordet Institute, Brussels, Belgium

10 Oct 2016

Treating CNS metastases from breast cancer with a peptide/paclitaxel conjugate

Prof Shou-Ching Tang - Augusta University Cancer Center, Augusta USA

10 Oct 2016

Highlights of ESMO 2016

Dr Andrés Cervantes - ESMO 2016 Scientific Chair

10 Oct 2016

Cabozantinib over sunitinib for metastatic renal cell carcinoma

Dr Toni Choueiri - Dana Farber Cancer Institute, Boston, USA

10 Oct 2016

Ceritinib following crizotinib relapse for ALK positive NSCLC

Dr Giorgio Scagliotti - University of Turin, Turin, Italy

9 Oct 2016

Significant survival gains with atezolizumab for NSCLC

Dr Fabrice Barlesi - Hôpital Nord, Marseille, France

9 Oct 2016

Video